CoVID19 test kit
Hymon SARS-COV-2 Test provides in vitro detection of coronavirus SARS-COV-2 in nasopharyngeal swab and other respiratory samples. The virus infects human and causes COVID-19.
The Test applies proprietary MoLock, a nanobody-based probe technology, and OT, a buffer system technology, to build the multiplexing RT-PCR kit that targets N and E genes of SARS-COV-2 to achieve ultrasensitive and robust detection of viral RNA in a same-tube, sample-to-result process. With overall turnaround time at 1.5 hours for 96 tests, the kit offers 5 copies/PCR detection limit of SARS-COV-2 with high specificity and maintains a consistent quality with an internal control. Hymon SARS-COV-2 Test Kit provides references to key clinical decisions such as confirmation of early infection, evaluation of therapeutic efficacy, and determination of negative conversion.
company certification
CE Certification